Implementing non-invasive prenatal testing (NIPT) in the Netherlands: An interview study exploring opinions about and experiences with societal pressure, reimbursement, and an expanding scope by Bakkeren, I.M. (Iris M.) et al.
J Genet Couns. 2019;00:1–10.	 	 	 | 	1wileyonlinelibrary.com/journal/jgc4
 
Received:	18	February	2019  |  Revised:	22	October	2019  |  Accepted:	22	October	2019
DOI:	10.1002/jgc4.1188		
O R I G I N A L  A R T I C L E
Implementing non‐invasive prenatal testing (NIPT) in the 
Netherlands: An interview study exploring opinions about and 
experiences with societal pressure, reimbursement, and an 
expanding scope
Iris M. Bakkeren1 |   Adriana Kater‐Kuipers2 |   Eline M. Bunnik2 |   Attie T. J. I. Go3 |   
Aad Tibben4 |   Inez D. de Beaufort2 |   Robert‐Jan H. Galjaard1 |   Sam R. Riedijk1
This	is	an	open	access	article	under	the	terms	of	the	Creative	Commons	Attribution‐NonCommercial‐NoDerivs	License,	which	permits	use	and	distribution	in	
any	medium,	provided	the	original	work	is	properly	cited,	the	use	is	non‐commercial	and	no	modifications	or	adaptations	are	made.
©	2019	The	Authors.	Journal of Genetic Counseling	published	by	Wiley	Periodicals,	Inc.	on	behalf	of	National	Society	of	Genetic	Counselors.
Robert‐Jan	H.	Galjaard	and	Sam	R.	Riedijk	are	considered	as	joint	senior	authors.	
1Department	of	Clinical	Genetics,	Erasmus	
MC,	University	Medical	Centre	Rotterdam,	
Rotterdam,	The	Netherlands
2Department	of	Medical	Ethics,	Philosophy	
of	Medicine	and	Medical	History,	Erasmus	
MC,	University	Medical	Centre	Rotterdam,	
Rotterdam,	The	Netherlands
3Department	of	Obstetrics	and	
Gynecology,	Erasmus	MC,	University	
Medical	Centre	Rotterdam,	Rotterdam,	 
The	Netherlands
4Department	of	Clinical	Genetics,	Leiden	
University	Medical	Center,	Leiden,	The	
Netherlands
Correspondence
Iris	M.	Bakkeren,	Department	of	Clinical	
Genetics,	Erasmus	MC,	University	Medical	
Centre	Rotterdam,	Rotterdam,	 
The	Netherlands.
Email:	i.bakkeren@erasmusmc.nl
Abstract
The	noninvasive	prenatal	test	(NIPT)	as	the	first	trimester	prenatal	screening	(FTS)	
for	 trisomies	21,	18,	and	13	 is	offered	 to	all	pregnant	women	 in	 the	Netherlands.	
NIPT	using	genome	sequencing	allows	for	an	expansion	of	the	scope	of	FTS	and	the	
introduction	of	NIPT	gives	 rise	 to	ethical	 and	 societal	 concerns	about	deliberated	
decision‐making,	pressure	to	engage	in	screening,	and	possible	lack	of	equal	access	
due	to	the	financial	contribution	(€175)	to	NIPT.	We	explored	the	opinions	and	expe‐
riences	of	pregnant	women,	who	were	offered	FTS,	about	these	concerns,	and	the	
possibility	of	a	broadened	scope.	Nineteen	pregnant	women	 representing	a	diver‐
sity	of	backgrounds	were	interviewed	using	a	semi‐structured	interview	guide.	Eight	
women	did	not	opt	for	prenatal	screening	while	11	did	(NIPT	=	4,	combined	test	=	7).	
Women	experienced	a	free	choice	to	accept	or	decline	prenatal	screening,	despite	
sometimes	receiving	advice	from	others.	Prior	to	pretest	counseling,	some	women	
had	already	deliberated	about	what	an	abnormal	 test	 result	would	mean	 to	 them.	
Others	accepted	or	declined	FTS	without	deliberation.	The	current	Dutch	policy	of	
requiring	 a	 co‐payment	was	 acceptable	 to	 some,	who	 believed	 that	 it	 functioned	
as	a	threshold	to	think	carefully	about	FTS.	Others	were	concerned	that	a	financial	
threshold	would	lead	to	unequal	access	to	screening.	Finally,	pregnant	women	found	
it	difficult	to	formulate	opinions	on	the	scope	of	FTS,	because	of	lack	of	knowledge.	
Life	expectancy,	severity,	and	treatability	were	considered	important	criteria	for	the	
inclusion	of	a	condition	in	NIPT.
K E Y W O R D S
Decision‐making,	deliberation,	expanding	scope,	genetic	counseling,	NIPT,	psychosocial,	
reimbursement,	societal	pressure
2  |     BAKKEREN Et Al.
1  | INTRODUC TION
The	noninvasive	prenatal	test	(NIPT)	provides	an	easy	form	of	first	
trimester	prenatal	screening	(FTS).	In	the	Netherlands,	NIPT	screens	
for	trisomies	21,	18,	and	13	and	is	offered	to	all	pregnant	women,	
costing	 them	€175.	When	using	 genome	 sequencing,	NIPT	 allows	
for	an	expansion	of	the	scope	of	FTS.	The	introduction	of	NIPT	gives	
rise	to	ethical	and	societal	concerns	about	deliberated	decision‐mak‐
ing,	pressure	to	engage	in	screening,	and	possible	lack	of	equal	ac‐
cess	due	to	the	financial	costs	of	NIPT.	This	study	examines	to	what	
extent	these	concerns	matter	to	pregnant	women	and	explores	their	
opinions	and	experiences	concerning	FTS.
In	 the	Netherlands,	 all	 pregnant	women	 can	 choose	 to	 have	 a	
screening	test	to	determine	their	chance	of	fetal	trisomies	21	(Down	
syndrome),	18	(Edwards	syndrome),	and	13	(Patau	syndrome;	Mersy	
et	al.,	2013).	From	2007	until	April	1,	2017	this	screening	was	mainly	
conducted	with	the	first	trimester	combined	test	(ftCT).	If	the	ftCT	
determines	an	increased	likelihood	(>1:200)	of	 (one	of)	these	com‐
mon	 aneuploidies,	 pregnant	 women	 could	 choose	 either	 invasive	
prenatal	 genetic	 testing	or	 refrained	 from	 further	 testing	 (Oepkes	
et	al.,	2016;	Taylor,	Chock,	&	Hudgins,	2014).	On	the	April	1,	2014,	
the	possibility	 to	opt	 for	 the	noninvasive	prenatal	 test	 (NIPT)	 in	 a	
national	implementation	study	‘trial	by	Dutch	laboratories	for	evalu‐
ation	of	non‐invasive	prenatal	testing’	(TRIDENT‐1)	was	added.
Since	 April	 1,	 2017,	 all	 pregnant	 women	 in	 the	 Netherlands	
have	a	choice	between	no	first	trimester	screening	(FTS),	the	ftCT,	
or	NIPT	within	 the	TRIDENT‐2	 study.	 First	 (and	 second)	 trimester	
screening	is	mainly	offered	by	primary	care	midwives,	in	a	separate	
consultation	with	a	funded	duration	of	30	min	(Martin	et	al.,	2015).	
At	the	moment	all	pregnant	women	in	the	Netherlands	must	pay	out	
of	pocket	for	the	ftCT	(€170),	and	NIPT	also	requires	a	€175	contri‐
bution.	Second‐trimester	screening	sonography	scans	are	fully	reim‐
bursed	(RIVM,	2018).
The	 introduction	 of	 NIPT	 provides	 easy	 accessible	 FTSUusing	
genome	sequencing,	NIPT	allows	for	an	expansion	of	the	scope	of	
FTS.	Pregnant	women	opting	for	the	ftCT	still	have	a	choice,	in	case	
of	an	increased	risk,	between	NIPT	or	invasive	prenatal	genetic	test‐
ing	as	the	follow‐up	test.	NIPT	entails	important	benefits	for	preg‐
nant	women:	first,	 it	 is	more	sensitive	and	specific	as	compared	to	
the	ftCT.	The	sensitivity	of	NIPT	is	97%	for	Down	syndrome,	90%	
for	Edwards	syndrome,	and	90%	for	Patau	syndrome,	while	the	com‐
bined	test	has	sensitivities	of	r	85%,	77%	and	65%	(RIVM,	2019)re‐
spectively.	Second,	the	use	of	NIPT	will	reduce	the	need	for	invasive	
procedures	 and	 the	 concurrent	 risks	 of	miscarriage.	However,	 the	
introduction	of	NIPT	also	raises	some	concerns.
First,	it	is	feared	that	NIPT	as	a	first‐tier	screening	test	may	lead	
to	routinization.	The	routinization	argument	is	a	container	concept,	
which	has	been	conceptually	 and	empirically	unraveled	elsewhere	
(Kater‐Kuipers,	de	Beaufort,	Galjaard,	&	Bunnik,	2018).	Routinization	
may	refer	to:	(a)	that	NIPT	may	lead	pregnant	women	to	venture	into	
first	trimester	prenatal	screening	less	thoughtfully,	(b)	that	in	the	ab‐
sence	of	a	risk	of	miscarriage,	NIPT	may	lead	to	societal	pressures	to	
participate	in	prenatal	screening	and	to	stigmatization	of	those	who	
forego	 screening	 (Lewis,	 Silcock,	 &	 Chitty,	 2013),	 and	 (c)	 because	
NIPT	can	be	conducted	early	in	the	pregnancy,	it	may	result	in	the	
trivialization	of	abortion	(Farrell,	Agatisa,	&	Nutter,	2014;	Farrimond	
&	Kelly,	2013).	However,	concerns	about	informed	decision‐making,	
pressure	to	test,	and	stigmatization	 lack	empirical	evidence,	which	
questions	their	validity	(Kater‐Kuipers,	Beaufort,	et	al.,	2018).
Second,	 there	 are	 concerns	 about	 the	 influence	 of	 reimburse‐
ment	 policies	 on	 pregnant	 couples’	 views	 and	 uptake	 of	 prenatal	
screening.	 Pregnant	 couples	might	 easily	 or	 thoughtlessly	 opt	 for	
reimbursed	screening,	whereas	nonreimbursed	screening	may	lead	
to	 unequal	 access	 (Health	 Council	 of	 the	 Netherlands,	 2016).	 As	
said	before,	at	the	moment	all	pregnant	women	in	the	Netherlands	
must	pay	a	contribution	for	the	first	trimester	screening.	In	contrast,	
second	trimester	screening	sonography	scans	are	fully	 reimbursed	
(RIVM,	2018).	The	uptake	of	first	trimester	screening	is	around	45%	
whereas	 over	 90%	 of	 pregnant	 women	 choose	 the	 fetal	 anomaly	
scan	in	the	second	trimester.	The	difference	in	reimbursement	pol‐
icies	might	be	one	of	the	reasons	why	the	uptake	of	these	tests	 is	
different,	besides	the	fact	that	many	women	opt	for	an	ultrasound	
to	see	their	unborn	child	(Bakker,	Birnie,	Pajkrt,	Bilardo,	&	Snijders,	
2012).
Third,	 whole	 genome	 NIPT	 can	 detect	 a	 wide	 range	 of	 fetal	
chromosome	abnormalities	 in	addition	 to	 trisomies	21,	18,	and	13	
(Morain,	Greene,	&	Mello,	2013).	At	the	moment,	pregnant	women	
in	 the	Netherlands	 can	 choose	 for	 a	NIPT	 that	 only	 reveals	 triso‐
mies	 21,	 18,	 and	 13,	 or	 a	 NIPT	 that	 also	 reveals	 abnormalities	 in	
other	 chromosomes,	 indicated	 as	 secondary	 findings.	However,	 in	
the	Netherlands	 fetal	 sex	 and	 sex	 chromosomal	 abnormalities	 are	
not	 communicated,	 because	 the	ministerial	 license	does	not	 allow	
analysis	of	 the	sex	chromosomes	 (Oepkes	et	al.,	2016).	Expanding	
the	 scope	 of	 NIPT	 could	 be	 beneficial	 for	 pregnant	 couples,	 be‐
cause	more	pathogenic	abnormalities	 in	the	fetus	can	be	detected	
(Tamminga	et	al.,	2015).	However,	concerns	on	this	expanding	scope	
of	NIPT	have	been	voiced.	Several	studies	have	suggested	that	an	
expanded	scope	of	NIPT	may	undermine	informed	decision‐making	
because	of	the	increased	quantity	and	complexity	of	pretest	infor‐
mation	counselors	have	to	offer	 (Dondorp	et	al.,	2015).	Moreover,	
people	 fear	 that	with	an	expansion	of	 the	 scope,	prenatal	 screen‐
ing	 is	 on	 a	 ‘slippery‐slope’	 towards	 screening	 for	minor	 abnormal‐
ities	 and	 cosmetic	 traits.	 Different	 studies	 have	 shown	 that	 both	
professionals	 and	pregnant	women	have	difficulty	deciding	where	
to	draw	the	line	for	an	expanded	NIPT	(Tamminga	et	al.,	2015;	van	
Schendel	et	al.,	2014).	In	practice,	the	expansion	of	NIPT	has	already	
started	 in	many	clinics	 in	many	developed	countries,	 including	the	
United	States	and	the	Netherlands	(Oepkes	et	al.,	2016;	Wapner	et	
al.,	 2015).	 An	 expanded	NIPT	 includes	 other	 trisomies	 in	 addition	
to	 trisomies	21,	 18,	 and	13	 and	 also	 subchromosomal	 aberrations	
and	microdeletions.	Professionals	indicate	an	urgent	need	for	ethical	
guidance	to	determine	an	appropriate	scope	of	NIPT	(Tamminga	et	
al.,	2015).	In	this	context,	knowledge	of	women's	preferences	with	
regard	to	the	scope	of	NIPT	is	indispensable.
The	aim	of	the	study	at	hand	is	to	examine	the	ethical	and	socie‐
tal	concerns	about	routinization,	societal	pressure,	reimbursement,	
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and	an	expanded	scope	of	NIPT.	 Interviews	with	pregnant	women	
regarding	 their	 views	 about	 NIPT,	 its	 characteristics,	 its	 (lack	 of)	
reimbursement,	and	 its	scope	were	conducted.	Previous	 interview	
studies	on	attitudes	of	pregnant	women	and	partners	regarding	NIPT	
mainly	focussed	on	how	pregnant	couples	view	NIPT	and	its	differ‐
ent	aspects,	but	remain	hypothetical	on	the	aspects	of	that	is,soci‐
etal	pressure	and	reimbursement	(Lewis	et	al.,	2013;	van	Schendel	
et	al.,	2014).	Furthermore,	most	studies	were	conducted	a	couple	of	
years	before	the	introduction	of	NIPT	as	a	first‐tier	screening	test,	
making	the	results	less	applicable	to	present	day	pregnant	couples.	
This	study	will	give	a	more	in‐depth	insight	of	the	views	and	opinions	
of	pregnant	women	who	have	made	the	decisions	about	whether	or	
not	to	engage	in	such	prenatal	screening	tests.
2  | METHODS
For	 this	 study	a	qualitative	 research	design	was	used.	 Semi‐struc‐
tured	 individual	 interviews	 were	 held	 to	 explore	 the	 experiences	
and	 opinions	 of	 pregnant	 women	 regarding	 first	 trimester	 pre‐
natal	 screening	 and	 in	 particular	 NIPT.	 Ten	 interviews	 were	 con‐
ducted	before	the	availability	of	NIPT	to	all	pregnant	women	in	the	
Netherlands,	 whereas	 nine	 interviews	 were	 conducted	 after	 this	
implementation.	All	women	provided	written	informed	consent	be‐
fore	participating	in	this	study.	The	research	ethics	review	commit‐
tee	(METC)	of	Erasmus	MC,	University	Medical	Centre	Rotterdam,	
exempted	this	study	(MEC‐2016‐399).
2.1 | Participants
Individual	semi‐structured	interviews	were	conducted	with	19	preg‐
nant	women	from	four	midwifery	practices	between	June	2016	and	
June	2017.	After	19	interviews	no	new	information	was	attained	and	
therefore	data	saturation	was	reached,	no	further	interviews	were	
conducted.	Women	were	recruited	through	four	different	midwifery	
practices	 across	 the	 country.	 The	 researchers	 deliberately	 sought	
to	include	women	with	different	ethnic	and	religious	backgrounds,	
educational	 levels,	 and	 socioeconomic	 status.	 However,	 women	
who	 signed	 up	 for	 the	 study	were	mostly	 Caucasian,	 highly	 edu‐
cated	women.	Women	were	 interviewed	 throughout	 all	 phases	of	
their	pregnancy.	All	19	women	were	offered	first	trimester	prenatal	
screening;	11	of	them	opted	for	prenatal	screening	(NIPT	or	ftCT),	
whereas	 eight	 did	 not.	 None	 of	 the	 pregnant	 women	 who	 chose	
for	 first	 trimester	 prenatal	 screening	 obtained	 high‐risk	 results.	
Characteristics	of	the	participants	can	be	seen	in	Table	1.
2.2 | Procedure
Pregnant	women	were	recruited	and	interviewed	by	two	of	the	re‐
searchers	(IMB	and	AKK).	Nine	interviews	were	held	in	person	and	
the	other	10	by	telephone.	The	interviews	were	guided	by	an	inter‐
view	guide	(see	Supplementary	Material),	and	if	necessary	follow‐up	
questions	were	asked.	The	individual	interviews	lasted	between	30	
and	60	min.	The	pregnant	women	received	a	€10	gift	card	for	their	
participation.
An	 interview	 guide	was	 developed	 in	 a	multidisciplinary	 team	
of	clinical	geneticists,	gynecologists,	medical	ethicists,	and	medical	
psychologists.	The	themes	found	to	be	relevant	for	the	 interviews	
were	discussed	and	appropriate	questions	were	formulated.	The	in‐
terview	guide	made	sure	that	the	interviews	entailed	a	reflection	on	
women's	own	choices	with	respect	to	screening,	their	views	on	the	
different	screening	modalities	(ultrasound,	combined	test,	NIPT),	the	
appropriate	scope	of	NIPT,	and	their	experiences	(if	any)	of	societal	
pressure	to	undergo	prenatal	screening	or	to	terminate	an	affected	
pregnancy.	 Furthermore,	 we	 included	 questions	 about	 the	 reim‐
bursement	 policies	 for	 the	 various	 screening	 tests	 and	 asked	 the	
pregnant	women	what	influence—if	any—the	reimbursement	policy	
had	on	their	choices	for	prenatal	screening.
2.3 | Data analysis
All	 interviews	were	 audio	 taped	 and	 transcribed	verbatim	by	 IMB	
afterwards.	After	transcription,	the	interviews	were	analyzed	using	
Nvivo	software.	Data	analysis	was	conducted	using	thematic	analy‐
sis	(Braun	&	Clarke,	2006).	Responses	in	the	interviews	were	coded	
independently	by	AKK	and	IMB.	Afterward,	these	codes	were	com‐
pared	 and	 any	 discrepancies	 were	 discussed	 until	 consensus	 was	
reached.	 From	 these	 codes	 topics	 were	 extracted,	 and	 clustered	
into	main	topics	and	subtopics	in	order	to	identify	important	themes	
in	the	interviews.	Representative	quotes	from	the	interviews	were	
translated	from	Dutch	to	English	and	presented	to	illustrate	the	dif‐
ferent	themes.
TA B L E  1  Characteristics	of	interviewed	pregnant	women
Mean age 31.5	years	(range	20–45)
Mean	gestational	age	at	interview 23.1	weeks	(range	9–40)
Nationality
Dutch 18	(94.7%)
Other 1	(5.3%)
Screening
No 8	(42.1%)
Yes,	ftCT 7	(36.8%)
Yes,	NIPT 4	(21.1%)
Education	levela
Highly	educated 12	(63.2%)
Lower	educated 7	(36.8%)
Religious
Yes 5	(26.3%)
No 14	(73.7%)
Children
Yes 10	(52.6%;	mean	=	1.8)
No 9	(47.4%)
aEducation	Level:	Highly	educated:	College	educated	or	higher.	
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3  | RESULTS
The	 four	 themes	 that	were	 examined	 during	 the	 interviews	were	
pregnant	women's:	(a)	reasons	for	choosing	first	trimester	prenatal	
screening	or	not	(routinization),	(b)	experiences	of	pressure	from	the	
social	environment	and	society,	(c)	thoughts	and	expectations	about	
payment	for	prenatal	screening,	and	(d)	views	on	the	possible	expan‐
sion	of	the	scope	of	prenatal	screening.	These	four	themes	will	be	
presented	consecutively	below.
3.1 | Women's views regarding prenatal 
screening and NIPT
Women	who	participated	in	the	interviews	had	various	reasons	to	ac‐
cept	or	reject	prenatal	screening.	Some	women	did	not	opt	for	screen‐
ing	because	they	did	not	think	about	it	at	all,	they	believed	they	were	
too	young	and	not	at	risk,	or	thought	the	test	result	of	the	ftCT	is	diffi‐
cult	to	interpret,	or	a	combination	of	these	considerations.	Others	pre‐
ferred	a	worry‐free	pregnancy	above	knowing	the	health	status	of	their	
fetus,	or	would	not	take	action	after	an	abnormal	test	result.	For	some,	
abortion	was	not	an	option	because	of	their	religious	beliefs	or	because	
they	thought	they	would	not	be	able	to	handle	its	psychological	burden.
Well,	at	my	age	anyway,	the	chance	is	just	a	bit	smaller	
[for	Down	syndrome].	Besides,	I	would	not	terminate	
my	pregnancy	if	it	[the	unborn	child]	does	have	Down	
syndrome.	They	could	also	see	it	at	the	20‐week	scan,	
so	I	can	still	prepare	myself	for	it.	(I9,	age	20,	no	pre‐
natal	screening)
The	pregnant	women	who	opted	for	first	trimester	screening	also	
gave	 various	 reasons.	 Some	 chose	 screening	 because	 they	 wanted	
information	about	 the	health	of	 their	child,	because	 they	wanted	 to	
have	the	possibility	to	end	their	pregnancy	in	case	of	an	abnormal	test	
result,	or	because	they	wanted	to	be	able	to	prepare	for	the	birth	of	a	
disabled	child.	
I	just	really	wanted	to	know	if	it	[the	unborn	child]	was	
healthy.	I	really	wanted	that	little	piece	of	certainty,	I	
really	liked	that.	(I7,	age	27,	combined	test)
The	characteristics	of	the	NIPT,	such	as	its	reliability	and	easiness	
compared	 to	 the	 ftCT,	make	 testing	more	attractive	 to	women.	Ten	
women	were	interviewed	before	NIPT	became	available	as	a	first‐tier	
test	 in	 the	 Netherlands.	Most	 of	 these	 women	 indicated	 that	 they	
would	have	opted	 for	NIPT	 if	 it	was	 available	 for	 them	during	 their	
pregnancy.	The	 interviewed	women	expected	an	 increase	 in	uptake	
with	 the	 introduction	 of	 NIPT,	 although	 women	 also	 thought	 that	
when	pregnant	women	do	not	want	to	participate	in	prenatal	screen‐
ing	they	still	will	not	opt	for	it.
You	are	going	to	find	out	whether	your	child	is	healthy	
or	not	[with	the	ftCT	and	NIPT],	and	many	people	do	
not	want	to	know	that.	(…)	There	might	be	somewhat	
more	[women	who	opt	for	NIPT	than	with	the	ftCT],	
because	 it	 is	 easier	 and	 more	 accessible	 (…).	 That	
could	 be	 the	 case,	 but	 I	 think	 that	 it	 [the	 uptake	of	
ftCT	vs.	NIPT]	would	not	differ	very	much.	 (I17,	age	
39,	combined	test)
A	few	participants	made	their	choice	concerning	prenatal	screen‐
ing	before	they	received	pretest	counseling,	based	on	information	on	
the	internet,	or	flyers,	or	peers’	experiences.	At	the	same	time	some	
women	had	a	general	concern	that	other	pregnant	women	might	not	
think	through	their	choice	for	NIPT,	that	some	accept	the	NIPT	offer	
thoughtlessly,	viewing	it	as	part	of	standard	procedure,	without	read‐
ing	information	leaflets	or	thinking	about	the	information	they	received	
during	counseling.	As	one	woman	indicated:
Because	I	think,	they	already	take	so	much	blood,	why	
do	you	not	add	that	[NIPT]	to	that	 [those	tests].	 (I3,	
age	32,	no	prenatal	screening)
Therefore,	 pretest	 counseling	 for	 FTS	 should	 emphasize	 choice	
awareness	 among	 pregnant	 women.	 According	 to	 the	 interviewed	
women,	 good	 counseling	 should	 further	 include	medical	 information	
about	the	test,	such	as	its	process,	the	reliability	and	explanation	about	
trisomies	21,	18,	and	13,	and	the	possible	next	steps.	A	few	participants	
also	mentioned	that	it	is	important	to	discuss	the	emotional	impact	of	
screening,	including	knowing	in	advance	what	they	want	to	do	with	the	
test	 result.	However,	 other	women	 indicated	 that	 they	 did	 not	 think	
about	what	to	do	with	the	test	result	before	engaging	in	prenatal	screen‐
ing.	They	first	wanted	to	wait	and	see	what	the	test	result	would	be.
3.2 | Experiences of pressure from social 
environment and society
Women	had	different	thoughts	about	and	experiences	with	social	and	
societal	influence	on	their	choice	for	first	trimester	prenatal	screen‐
ing.	Most	of	the	women	indicated	that	their	social	environment	did	
not	influence	their	opinion	about	prenatal	screening.	However,	some	
women	 indicated	 that	 their	 social	 environment	 did	 influence	 their	
choice.	These	pregnant	women	did	not	experience	this	influence	as	
pressure:	they	stated	that	they	could	still	make	their	own	individual	
choice.	Most	women,	furthermore,	stated	that	the	counseling	by	the	
midwife	did	not	change	their	opinion,	but	more	so	strengthened	it.
Yes	I	told	her	[the	midwife]	in	advance	[that	I	did	not	
want	to	opt	for	screening].	But	she	said	she	wanted	to	
explain	everything	about	the	screening	to	me,	so	she	
did.	But	that	did	not	make	me	change	my	mind.	(I15,	
age	35,	no	prenatal	screening)
A	 few	 younger	women	 (age	 range:	 24–30)	 in	 our	 sample	 ex‐
pected	influence	from	family	or	friends	on	their	choice	when	they	
would	 be	 older,	 because	 then	 they	 would	 be	 at	 higher	 risk	 and	
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family	 and	 friends	 would	 stimulate	 them	 to	 opt	 for	 screening.	
Some	of	these	women	also	indicated	that	friends	and	family	asked	
them	the	question	why	they	opted	for	screening	while	they	were	
young.	Two	women	mentioned	a	certain	influence	toward	testing	
from	healthcare	professionals	and	got	the	idea	that	testing	is	more	
self‐evident	to	professionals.
Nobody said	 [during	 the	counseling	session]:	you can 
also do nothing.	(I11,	age	40,	NIPT)
A	 few	 women	 believed	 that	 society	 participation	 in	 prenatal	
screening	 is	 portrayed	 as	 being	 self‐evident	 amongst	 others	 caused	
by	media	attention	for	the	 introduction	of	NIPT.	 It	 is	presented	as	a	
very	reliable	test,	and	as	an	improvement	of	prenatal	screening.	It	is	ex‐
pected	that	every	woman	would	opt	for	it.	Some	women	also	had	cer‐
tain	worries	that	being	pregnant	becomes	medicalized,	or	that	utilizing	
available	tests	becomes	the	social	norm.	Furthermore,	concerning	the	
termination	of	pregnancy,	a	few	women	had	the	opinion	that	there	is	
certain	societal	pressure,	in	two	directions:	one	woman's	opinion	was	
that	terminating	a	pregnancy	is	more	self‐evident	than	to	carry	an	af‐
fected	pregnancy	to	term.
You	will	 be	 judged	 [by	 society]	when	 you	decide	 to	
keep	a	baby	with	a	severe	disorder	while	you	had	the	
possibilities	to	detect	the	disorder.	(I12,	age	33,	NIPT)
Another	woman	had	the	opinion	that	it	is	less	acceptable	to	choose	
termination	of	pregnancy	and	stressed	the	importance	of	complete	in‐
formation	in	the	counseling.
I	think	that	people	are	opposed	to	it	and	look	at	you	
and	ask	if	you	are	sure	to	do	it	[terminating	the	preg‐
nancy].	I	think	that	people	do	not	easily	opt	for	it	and	
also	do	not	easily	accept	from	others	that	they	choose	
it.	(…)	Because	people	do	not	really	know	the	conse‐
quences	of	having	such	a	child	[with	a	disability].	(I17,	
age	33,	combined	test)
Most	of	the	participants	did	not	experience	pressure	from	the	soci‐
ety	to	test	or	not	test.	Most	women	experienced	that	there	is	sufficient	
freedom	to	refrain	from	screening,	and	most	women	believed	that	you	
are	 free	to	either	carry	an	affected	pregnancy	to	term	or	 to	choose	
termination	of	the	pregnancy.	The	pregnant	women	also	believed	that	
in	society	there	is	not	one	major	opinion	on	the	termination	of	preg‐
nancy;	 there	 are	 different	 opinions,	 influenced	 by,	 amongst	 others,	
culture	and	religious	beliefs.
3.3 | Thoughts and expectations about payment for 
prenatal screening
Opinions	on	the	role	of	payment	for	prenatal	screening	were	quite	
diverse.	Some	women	thought	that	having	to	pay	for	a	test	did	not	
have	any	impact	on	their	decision	about	prenatal	screening.	Others	
thought	that	asking	a	fee	might	have	impact	on	their	personal	choice	
for	 screening.	They	expected	 to	be	 influenced	by	 the	price	of	 the	
test,	and	probably	would	not	opt	 for	 it	 if	 it	were	expensive.	Some	
thought	 that	 if	 the	 tests	were	 free	of	charge	 they	would	certainly	
opt	 for	 screening,	whereas	 they	would	not	 take	part	 if	 they	were	
asked	to	pay.
If	I	did	not	have	to	pay	I	would	definitely	do	it	[the	com‐
bined	test].	But	the	fact	that	I	have	to	pay	really	makes	
me	think	it	is	a	lot	of	money.	I	almost	did	not	want	to	
do	it	[the	combined	test].	(I2,	age	29,	combined	test)
A	few	women	thought	€175	is	a	lot	of	money	for	people	with	lim‐
ited	financial	resources,	while	others	thought	that	 it	 is	acceptable	to	
ask	that	fee.	Some	women	indicated	that	they	think	that	a	reimburse‐
ment	of	the	test	carries	the	message	that	it	is	a	standard	practice.
But	if	it	is	free	of	charge,	then	it	is	more	as	if	it	is	in‐
cluded	in	the	total	package	[of	tests	during	pregnancy],	
like	 the	 ultrasounds.	 You	 do	 not	 feel	 obliged,	 but	 it	
seems	that	it	is	included.	(I8,	age	26,	combined	test)
Moreover,	women	thought	that	more	pregnant	women	would	opt	
for	screening	if	it	was	free	of	charge	and	the	uptake	would	increase.	
Therefore	several	women	suggested	that	asking	a	fee	might	function	
as	a	threshold	and	makes	pregnant	women	aware	that	it	is	an	import‐
ant	choice	they	have	to	make.
I	do	not	know,	if	 it	 is	completely	reimbursed	it	 is	ac‐
cessible	 for	 everybody	 [NIPT].	 I	 think	 that	 people	
would	take	the	test	more	often.	But	on	the	other	hand	
you	do	have	to	think	about	it	very	well,	about	the	con‐
sequences.	Maybe	if	it	is	too	accessible	people	do	not	
think	about	it	good	enough.	So	maybe	asking	money	
[for	NIPT]	could	help.	(I10,	age	29,	NIPT)
A	few	women	stated	that	it	is	your	own	choice	to	become	pregnant	
and	therefore	you	have	to	pay	for	a	prenatal	screening	test	yourself.	
Other	women	thought	that	prenatal	screening	should	be	free	of	charge	
in	order	to	eliminate	any	threshold	and	make	the	test	equally	accessible	
for	all	women.	
People	differ	 in	 their	 incomes	and	then	 [by	asking	a	
fee]	 you	 get	 involved	 in	 the	 rich	 versus	 poor	 argu‐
ment.	I	believe	that	in	healthcare	income	should	not	
matter,	especially	not	 in	the	case	of	an	unborn	child	
(I18,	age	33,	no	prenatal	screening)
3.4 | Expansion of the scope of prenatal screening
The	discussion	on	 the	expanding	 scope	of	prenatal	 screening	was	
often	difficult	 to	understand	 for	women.	When	asked	about	 their	
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preferences,	 benefits,	 and	 disadvantages	 of	 an	 expanded	 scope,	
women	found	it	difficult	to	formulate	their	opinions	because	of	lack	
of	knowledge.
I	do	not	dare	 to	 say	something	about	 that.	 I	did	not	
learn	about	what	kind	of	abnormalities	there	could	be,	
because	I	assume	that	it	[the	child]	was	just	healthy.	In	
case	of	an	abnormal	test	result	of	course	you	are	going	
to	look	at	what	it	means.	(I7,	age	27,	combined	test)
Some	women	expressed	reservations	regarding	the	expansion	of	
prenatal	screening.	One	woman	mentioned	that	pregnant	women	(and	
their	partners)	would	not	have	worry‐free	pregnancies	anymore	if	ab‐
normalities	were	detected.	Others	thought	that	it	is	a	step	too	far	or	
felt	it	would	be	like	playing	God.	Furthermore,	a	few	women	thought	
that	society	wants	to	exclude	all	possible	abnormalities	and	feared	that	
society	tends	to	select	perfect	children	and	would	not	accept	people	
with	a	disability	anymore.	Moreover,	they	feared	that	abortion	for	less	
severe	abnormalities	might	also	become	accepted.
Just	 in	 general,	 I	 am	 opposed	 to	 everything	 being	
placed	in	a	medical	framework.	That	you	can	already	
know	so	many	things	in	advance	[before	the	baby	is	
born].	 The	 question	 is	 of	 course	where	 this	 [expan‐
sion]	will	stop.	 (…)	So	I	think	I	am	just	against	 it	 [the	
expansion]	going	on	and	on.	(I18,	age	30,	no	prenatal	
screening)
Other	women	thought	that	an	expansion	of	 the	scope	of	prena‐
tal	 screening	 is	positive,	because	 it	provides	certainty,	or	 they	were	
in	favor	of	an	expansion	because	it	might	prevent	a	long	search	for	a	
diagnosis	when	a	child	is	born	with	unexplained	symptoms.
I	 would	 appreciate	 it	 when	 the	 test	 becomes	 ex‐
panded.	 I	 think	 it	 is	 something	 good	because	 it	 just	
provides	 more	 certainty.	 You	 know,	 you	 are	 giving	
birth	to	a	whole	new	life.	(I7,	age	27,	combined	test)
Especially	the	question	on	the	kind	of	fetal	abnormalities	pregnant	
women	want	to	know	was	difficult	for	women	to	answer,	because	of	
unfamiliarity	with	such	abnormalities.	 In	the	interviews	several	cate‐
gories	of	disorders	were	discussed	such	as	early	onset,	late	onset,	and	
neurological	disorders,	based	on	categories	as	used	in	clinical	genetics	
practice.	Women	who	positively	evaluate	(a	certain)	expansion	of	the	
scope	often	indicated	that	disorders	with	limited	or	no	life	expectancy	
should	be	considered	 for	 inclusion	 in	 the	 test.	Other	 considerations	
related	to	the	question	on	which	disorders	should	be	included	in	the	
test,	are	the	severity	of	the	disorder,	and	the	child's	prospects	of	living	
an	independent	and	happy	life.
It	is	difficult.	My	idea	would	be	that	it	[NIPT]	should	
concern	 severely	 disabled	 children.	 Children	 who	
could	 never	 live	 independently,	 who	 need	 a	 lot	 of	
medical	care,	where	you	ask	yourself	if	they	could	be	
happy	at	all.	(I11,	age	40,	NIPT)
However,	women	said	 that	 it	 is	hard	 to	say	something	 regarding	
such	a	difficult	and	hypothetical	situation	of	expecting	a	child	with	a	se‐
vere	disorder	and	regarding	what	they	would	do	with	such	knowledge.	
They	did	not	know	what	they	would	decide	in	the	case	of	an	abnormal	
test	result.	However,	the	different	perceptions	pregnant	women	have	
of,	for	example,	Down	syndrome	suggest	that	women	have	different	
perceptions	of	severity	and	quality	of	life.	Some	women	believed	that	
Down	syndrome	is	not	sufficiently	severe	and	they	would	not	termi‐
nate	 the	 pregnancy	 for	 it.	Others	would	 terminate	 a	 pregnancy	 for	
Down	syndrome	because	 the	child	will	 always	need	care	and	might	
have	many	problems.
Another	important	argument	was	life	expectancy,	which	is	often	
a	reason	not	to	include	late	onset	disorders	in	a	screening	test.	They	
believed	that	one	can	have	a	joyful	life	until	your	40s	or	50s,	without	
knowing	about	the	disease,	and	maybe	there	will	be	new	treatments	
discovered	in	the	meantime.	In	contrast,	a	few	women	indicated	that	
they	probably	would	want	 to	know	 late	onset	diseases	because	 it	
enables	you	to	prepare	for	your	own	future	and	the	child's	future.	
Some	women	believed	that	an	expanded	test	might	enforce	striving	
for	a	perfect	child	and	also	mild	disorders	might	be	included	in	pre‐
natal	screening	 in	 the	 future.	They	were	worried	about	where	the	
expansion	would	stop.
4  | DISCUSSION
Pregnant	women	gave	various	reasons	to	accept	or	reject	the	first	
trimester	prenatal	screening.	Women	mainly	chose	for	FTS	to	pre‐
pare	for	the	birth	of	an	affected	child,	or	to	terminate	an	affected	
pregnancy.	Preferring	a	worry‐free	pregnancy	or	not	wanting	to	take	
action	after	an	abnormal	test	result	was	the	main	reason	for	declining	
FTS.	In	concordance	with	other	studies,	NIPT	was	preferred	over	the	
ftCT	by	most	women	because	of	its	reliability	(Chetty,	Garabedian,	&	
Norton,	2013;	van	Schendel	et	al.,	2016).	Some	participating	women	
would	 terminate	 a	 pregnancy	 in	 case	 of	 an	 abnormality;	 others	
would	never	consider	a	termination.
With	regard	to	the	influence	of	pretest	prenatal	counseling	on	
the	decision	whether	or	not	to	participate	in	FTS,	some	pregnant	
women	already	made	their	choice	about	screening	before	visiting	
their	 obstetric	 caregiver,	whereas	others	made	 this	 choice	 after	
counseling.	Most	 women	 indicated	 that	 counseling	 for	 first	 tri‐
mester	 screening	 should	 both	 include	 information	 on	 the	 tests,	
the	process,	and	the	conditions	screened	for,	as	well	as	a	discus‐
sion	on	the	emotional	 impact	of	screening	and	the	possibility	of	
receiving	an	abnormal	 test	 result,	which	has	been	described	be‐
fore	(Martin,	Hutton,	Spelten,	Gitsels‐van	der	Wal,	&	van	Dulmen,	
2014).
Pregnant	women	indicated	that	it	is	important	that	women	think	
about	what	they	would	do	with	the	results	from	prenatal	screening	
beforehand,	 which	 is	 also	 underlined	 by	 healthcare	 professionals.	
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Deliberation,	defined	as	the	weighing	and	considering	of	what	pro‐
spective	parents	consider	to	be	a	worthy	life	for	their	child	and	what	
a	 termination	of	pregnancy	would	mean	 to	 them,	 is	 seen	as	a	key	
aspect	of	informed	decision‐making	(Riedijk	et	al.,	2014).	However,	
a	few	interviewed	women	stated	that	they	did	not	deliberate	them‐
selves,	even	not	after	pretest	counseling,	because	they	want	to	take	
the	screening	process	step	by	step	and	would	only	start	considering	
what	they	would	do	with	an	abnormal	test	result	when	they	actually	
receive	one.	To	our	best	knowledge	this	discrepancy	is	not	found	in	
previous	 studies,	 although	one	 study	did	 find	 that	 not	wanting	 to	
think	about	what	to	do	with	a	possible	abnormal	test	result	can	be	
a	reason	for	pregnant	women	to	decline	prenatal	screening	(Garcia,	
Timmermans,	&	van	Leeuwen,	2008a).	 This	 discrepancy	gives	 rise	
to	the	question	what	should	be	the	focus	of	the	prenatal	screening	
counseling.Currently,	 the	main	 focus	 of	 pretest	 counseling	 is	 pro‐
viding	information	(Martin	et	al.,	2014),	but	our	results	suggest	that	
merely	 providing	 information	 is	 outdated:	 some	 women	 prioritize	
deliberation	about	their	choice.	Other	studies	also	found	that	preg‐
nant	women	want	more	than	only	information	provision.	They	would	
like	to	have	decision‐making	support	or	even	advice	from	their	mid‐
wives,	whether	or	not	to	test	(Martin	et	al.,	2013).	These	results	also	
show	 that	 women's	 personal	 information	 needs	 and	 preferences	
regarding	deliberation	differ.	This	requires	personalized	counseling	
in	which	the	counselor	addresses	such	personal	needs.	Previous	re‐
search	found	that	midwives	feel	more	comfortable	with	providing	in‐
formation	than	with	inquiring	about	the	feelings	and	thoughts	of	the	
pregnant	couple	(Martin	et	al.,	2014).	Future	research	could	focus	on	
the	best	way	to	layout	a	pretest	counseling	session	for	first	trimester	
prenatal	 screening,	 to	balance	 information	provision	 and	delibera‐
tion	support,	and	make	midwives’	task	a	little	less	complex.	Also,	a	
deliberation‐focused	approach	to	pretest	counseling	might	need	to	
be	differentiated,	as	a	subgroup	of	women	want	to	take	part	in	the	
first	trimester	prenatal	screening	without	imagining	what	a	detected	
abnormality	might	mean	to	them	and	deliberating	what	reproductive	
decision	they	would	make	in	response.	To	respect	the	autonomy	of	
these	women,	they	should	be	allowed	to	access	screening	without	
partaking	in	deliberation.
Pregnant	women	feel	like	they	are	free	to	have	their	own	opin‐
ion	about	the	first	trimester	prenatal	screening.	They	made	different	
choices	with	regard	to	first	trimester	prenatal	screening,	but	all	felt	
that	they	could	make	these	decisions	independently,	without	pres‐
sure	from	others.	Some	of	the	women	indicated	that	their	surround‐
ings	influenced	their	choice,	such	as	their	partner,	parents,	friends,	
or	family	with	(shared)	beliefs	or	views	of	life,	or	their	obstetric	care‐
givers.	These	pregnant	women	did	not	experience	this	influence	as	
pressure:	they	stated	that	they	could	still	make	their	own	individual	
choice.	This	phenomenon	was	described	in	the	literature	before,	in	a	
study	in	which	it	was	examined	whether	prenatal	screening	programs	
allow	pregnant	women	to	make	autonomous	choices.	The	women	in	
that	study	also	stated	that	they	were	influenced	by	others	during	the	
decision‐making	process,	such	as	their	partners,	their	midwives,	and	
society,	but	they	made	their	own	choices	without	pressure	by	others	
(Garcia,	Timmermans,	&	van	Leeuwen,	2008b;	van	der	Steen	et	al.,	
2018).	These	results	suggest	that	the	concern	that	NIPT	will	lead	to	
a	societal	pressure	to	take	part	in	screening	and/or	to	terminate	an	
affected	pregnancy	(Gekas	et	al.,	2016),	is	contradicted	in	this	study.	
This	suggests	that,	for	the	women	pretest	counseling	in	the	context	
of	NIPT,	emphasized	freedom	of	choice.
So,	pregnant	women	do	not	personally	experience	any	pressure	
to	 (not)	 engage	 in	 prenatal	 screening,	 however,	 some	of	 them	did	
express	the	concerns	that	in	society	there	are	certain	expectations	
with	regard	to	participation	 in	screening	and	either	 termination	of	
an	affected	pregnancy,	or	 carrying	 this	pregnancy	 to	 term.	Earlier	
research	has	also	shown	that	pregnant	women	are	worried	that	NIPT	
may	lead	to	pressure	to	engage	in	screening;	however,	none	of	these	
studies	described	pregnant	women	experiencing	this	pressure	them‐
selves	(Lewis	et	al.,	2013;	van	Schendel	et	al.,	2014).
Pregnant	women	differened	in	their	opinions	regarding	the	re‐
imbursement	of	first	trimester	prenatal	screening.	These	different	
views	 could	 be	 explained	 by	 differences	 in	 test	 choice,	 personal	
(financial)	situation,	and	other	aspects.	Pregnant	women	did	agree	
that	 a	 lack	 of	 reimbursement	 could	 result	 in	 unequal	 access	 to	
healthcare.
Furthermore,	pregnant	women	agreed	that	reimbursing	a	screen‐
ing	test	carries	the	message	that	the	test	is	standard	practice,	as	can	
be	 seen	with	 the	 second	 trimester	 sonography	scan,	of	which	 the	
uptake	is	over	90%	in	the	Netherlands	(Liefers,	Cruijsberg,	&	Atsma,	
2017).	 Pregnant	women	believed	 that	 by	 reimbursing	 first	 trimes‐
ter	 screening,	 the	 uptake	will	 increase	 and	women	might	 venture	
into	 prenatal	 screening	 less	 thoughtfully.	 Some	 women	 indicated	
that	asking	a	 (small)	 fee	made	them	think	about	their	choice.	They	
believed	that	it	would	also	make	other	pregnant	women	aware	that	
prenatal	 screening	 is	 a	 personal,	 important	 choice.	However,	 they	
did	feel	that	for	some	women	even	a	small	fee	might	be	too	much,	
therewith	causing	these	women	to	forego	participating	in	screening,	
even	if	they	wanted	to.	In	sum,	women	underlined	the	importance	of	
informed	choice,	to	which	a	small	fee	might	be	conducive,	but	that	
should	not	 be	 at	 the	 expense	of	 equal	 access.	 This	 again	 stresses	
the	influence	of	how	screening	is	organized	on	the	women's	choices,	
and	demands	that	in	the	screening	offer	and	pretest	counseling	the	
choice	aspect	is	emphasized.
These	results	show	that	both	scenarios,	a	reimbursed	screening	
offer	 and	 a	 non‐reimbursed	 screening	 offer,	 might	 challenge	 the	
nondirectiveness	of	the	screening	offer	and	the	related	counseling,	
whereby	nondirective	means	‘withholding	any	normative	judgment	
regarding	 the	 obtaining	 and	 application	 of	 genetic	 information’	
(Oduncu,	2002).	Reimbursed	first	trimester	prenatal	screening	might	
imply	for	pregnant	women	that	the	screening	test	is	a	good	quality	
test,	and	participating	in	this	test	is	self‐evident	and	part	of	routine	
antenatal	care.	By	contrast,	a	nonreimbursed	screening	offer	might	
imply	that	 the	test	offered	 is	not	seen	as	an	 important	or	of	good	
quality	by	the	healthcare	providers,	and	therefore	pregnant	women	
would	not	want	to	opt	for	it.	The	effect	of	either	message	should	be	
minimized	in	the	counseling	by	explaining	that	while	the	test	is	reim‐
bursed,	women	are	still	free	to	not	opt	for	the	test,	or	that	while	the	
test	is	not	reimbursed,	it	is	a	good	test	that	might	provide	options	to	
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women.	Adequate	pretest	counseling	is	the	most	important	resource	
we	have	to	counteract	any	negative	effects	of	(not)	reimbursing	first	
trimester	prenatal	screening.
Finally,	a	possible	expanding	scope	of	NIPT	turned	out	to	be	a	
difficult	 discussion	 point	 for	 pregnant	 women.	 Pregnant	 women	
found	it	difficult	to	make	statements	about	the	expansion	of	NIPT	
because	they	were	unfamiliar	with	other	disorders	than	the	common	
trisomies	currently	included	in	first	trimester	screening.	In	the	dis‐
cussion,	various	categories	were	used,	that	is,	early	onset/late	onset	
and	actionable/non‐actionable.	Pregnant	women	were	also	not	al‐
ways	familiar	with	these	categories,	 in	such	cases	examples	to	ex‐
plain	the	categories	were	used,	but	the	categories	did	make	it	easier	
for	them	to	elaborate	on	the	screening	offer.
Some	 women	 were	 enthusiastic	 about	 an	 expansion	 because	
they	 thought	 that	 obtaining	more	 information	 is	 something	 good.	
Others,	however,	were	hesitant	toward	the	expansion	of	NIPT	and	
expressed	 the	 fear	 of	 a	 possible	 slippery	 slope.	 The	 interviewed	
pregnant	women	were	made	aware	of	the	existence	of	a	large	num‐
ber	of	serious	conditions	other	than	trisomies	21,	18,	and	13	through	
this	discussion,	and	some	of	 them	 linked	 this	 to	 their	own	unborn	
child.	 Having	 this	 discussion	 could	 be	 burdensome	 for	 pregnant	
women,	who	could	start	questioning	whether	they	are	the	ones	hav‐
ing	to	decide	on	the	screening	offer.
Analysis	of	the	responses	given	by	the	pregnant	women	on	the	
questions	 regarding	 the	scope	of	NIPT	showed	that	 they	consider	
three	things	to	be	important	in	deciding	whether	or	not	to	screen	for	
a	certain	condition:	(a)	severity,	(b)	life	expectancy,	and	(c)	the	pos‐
sibility	of	an	independent	and	happy	life.	If	a	condition	would	have	
(one	of)	these	characteristics	most	women	agreed	that	it	should	be	
included	in	the	screening.
In	 the	 literature,	 to	 help	women	make	 individualized	 decisions	
about	 the	scope	of	prenatal	 screening,	 it	has	been	suggested	 that	
women	 should	 choose	 from	 a	menu	 of	 options	 (Bunnik,	 de	 Jong,	
Nijsingh,	&	de	Wert,	2013),	with	different	categories	of	conditions	
included	 in	 the	 screening	 offer.	 Also,	 in	 another	 interview	 study	
pregnant	women	 favored	 ‘pure	 choice’	model	 for	 expanded	NIPT,	
wherein	 reproductive	 autonomy	 and	 informed	 choice	 are	 used	 to	
justify	 any	 prenatal	 screening	 decision	 a	 women	 wants	 to	 make	
(Vanstone,	Cernat,	Nisker,	&	Schwartz,	2018).	According	to	the	find‐
ings	 of	 this	 study,	 such	models	would	 lead	 to	 practical	 problems:	
women	had	different	interpretations	of	categories	and	found	it	hard	
to	imagine	what	learning	particular	test	results	might	mean	to	them	
and	their	child.	Moreover,	women	had	little	knowledge	of—or	expe‐
rience	with—conditions	that	could	potentially	be	included	in	the	test,	
which	raised	the	question	whether	women	can	make	an	 informed,	
autonomous	choice.	From	this	the	conclusion	could	be	derived	that	
the	scope	of	NIPT	should	mainly	be	determined	by	experts,	not	by	
women	themselves.	Which	experts	should	decide	on	the	scope	of	
NIPT	should	be	determined	by	future	research.	Based	on	earlier	re‐
search	an	expert	panel	in	the	Netherlands	could	include	midwives,	
gynecologists,	clinical	geneticists,	laboratory	specialists,	policy	mak‐
ers,	 and	 ethicists	 (de	 Jong	 et	 al.,	 2013;	 Kater‐Kuipers,	 Bunnik,	 de	
Beaufort,	&	Galjaard,	 2018).	Nevertheless,	 opinions	 of	women	 on	
the	scope	of	prenatal	screening,	as	found	in	this	study,	are	important	
inputs	for	the	determination	of	the	scope.
A	second	issue	raised	by	the	expanded	scope	and	its	related	in‐
formed	choice	 is	that	some	interviewed	women	wanted	to	receive	
the	 test	 results	 first,	 and	 only	 after	 something	 of	 relevance	 has	
been	found,	they	would	wish	to	learn	more	detailed	information	on	
the	 condition	 detected.	 These	 findings	 suggest	 that	 in	 case	 of	 an	
expanded	NIPT	women	might	prefer	a	 layered	counseling	wherein	
information	in	several	stages	can	be	provided	to	women	in	order	to	
prevent	 information	overload,	 as	 is	 proposed	 in	 a	 layered	 consent	
model	 for	 personal	 genetic	 tests	 (Bunnik,	 Janssens,	 &	 Schermer,	
2013).	Personal	preferences	regarding	informational	need	and	delib‐
eration	could	therewith	be	taken	into	account.
4.1 | Strengths and limitations
The	 strength	 of	 this	 study	 is	 that	 we	 included	 pregnant	 women	
from	different	 regions	 in	 the	Netherlands,	 aiming	 to	 include	vary‐
ing	opinions	within	our	 sample.	Furthermore,	we	 included	women	
with	different	test	choices,	to	make	sure	that	all	choices	(no	prena‐
tal	screening,	NIPT,	and	the	ftCT)	were	well	represented	within	our	
sample.	Finally,	we	held	these	interviews	right	before	and	right	after	
the	 introduction	of	NIPT	 as	 a	 first	 trimester	 screening	 test	 for	 all	
pregnant	women	in	the	Netherlands,	making	it	a	current	and	non‐hy‐
pothetical	matter	for	all	interviewed	pregnant	women.
For	this	study	women	signed	up	themselves,	which	may	have	
caused	 a	 bias	 in	 our	 pregnant	 population.	Women	who	 are	will‐
ing	to	participate	in	an	interview	about	prenatal	screening,	might	
have	different	characteristics	and	opinions	compared	to	pregnant	
women	willing	not	to	be	interviewed.	This	might	explain	why	in	our	
pregnant	group	more	 than	half	 (11	out	of	19)	of	 the	 interviewed	
pregnant	women	opted	for	NIPT	or	 the	ftCT,	whereas	 in	 the	en‐
tire	Dutch	pregnant	population	 less	than	half	 (45%)	opts	for	 first	
trimester	screening.	Therefore,	the	interpretation	of	these	results	
must	be	performed	with	caution,	 as	 these	might	not	be	general‐
izable	 to	 the	entire	Dutch	pregnant	population.	Furthermore,	 al‐
though	 we	 actively	 sought	 other	 target	 groups,	 mostly	 Dutch,	
highly	educated,	nonreligious	women	participated,	which	may	also	
cause	 problems	 in	 the	 generalizability	 of	 the	 results.	 Also,	 some	
of	the	 interviews	were	conducted	before	the	availability	of	NIPT	
to	 all	 pregnant	women	 in	 the	Netherlands,	 whereas	 other	 inter‐
views	were	conducted	after	 its	 implementation,	which	may	have	
elicited	 different	 opinions.	 Finally,	 in	 our	 pregnant	 group	 most	
women	were	highly	educated	(12	out	of	19)	of	which	most	(9	out	
of	12)	chose	for	either	the	combined	test	or	NIPT.	In	the	lower	ed‐
ucated	group	(7	women)	only	two	women	chose	for	first	trimester	
prenatal	screening.	Because	we	conducted	a	qualitative	interview	
study,	we	are	not	able	to	draw	conclusions	or	elaborate	on	the	fact	
that	more	highly	educate	women	opted	for	first	trimester	prena‐
tal	 screening	 than	 lower	educated	women.	However,	 this	 finding	
is	in	line	with	previous	research	which	concluded	that	higher	edu‐
cated	women	opt	for	NIPT	more	often	(Gil,	Giunta,	Macalli,	Poon,	
&	Nicolaides,	2015).
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5  | CONCLUSION
Our	study	shows	that	there	is	a	varying	and	broad	range	of	opin‐
ions	 about	 first	 trimester	 prenatal	 screening,	 NIPT,	 pressure	 to	
test,	 the	 reimbursement	 of	 screening	 and	 the	 expanding	 scope	
among	 pregnant	 women	 in	 the	 Netherlands.	 Women	 feel	 that	
they	have	a	free	choice	to	opt	for	or	decline	prenatal	screening,	
even	though	they	sometimes	receive	advice	from	others	for	their	
decision.	 Adequate	 pretest	 counseling	 is	 important	 to	 maintain	
this	experience	of	choice	liberty	now	that	NIPT	has	become	part	
of	 the	 screening	 offer.	 However,	 counseling	 might	 need	 a	 shift	
in	 focus	 toward	 deliberation	 about	 what	 women	want	 to	 know	
about	the	health	of	their	child	and	what	they	want	to	do	with	the	
results,	taking	into	account	personal	 informational	needs—which	
is	 already	 started	 in	 all	 Dutch	 training	 institutions	 and	midwife	
practices.	The	significance	of	pretest	counseling	for	first	trimester	
screening	 continues	 to	 be	 a	 factor	 of	 great	 attention.	However,	
our	 study	clearly	 shows	 two	 important	 social	 issues	 that	 should	
be	addressed	in	counseling.	First	of	all,	freedom	of	choice	should	
be	emphasized	and	 second,	possible	messages	deriving	 from	ei‐
ther	 reimbursed	 or	 nonreimbursed	 screening	 should	 be	 mini‐
mized.	 Most	 women	 felt	 that	 not	 fully	 reimbursing	 screening	
could	 prevent	 the	 routinization	 of	 NIPT,	 but	 that	 this	 may	 also	
cause	 unequal	 access	 to	 healthcare.	 Furthermore,	 women	 had	
difficulty	making	statements	about	expanding	the	scope	of	NIPT,	
but	 agreed	 that	 determining	 the	 scope	 should	 mainly	 be	 based	
on	severe,	 life‐threatening	disorders.	Finally,	our	results	suggest	
that	 the	scope	of	NIPT	should	be	determined	by	experts	 (in	 the	
Netherlands	these	could	include	midwives,	gynecologists,	clinical	
geneticists,	 laboratory	 specialists,	 policy	 makers,	 and	 ethicists),	
not	by	women	themselves.
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